IRIS - Res&Arch Institutional Research Information System - Research & Archive

VEDOVATI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.035
AS - Asia 2.631
EU - Europa 2.103
SA - Sud America 573
Continente sconosciuto - Info sul continente non disponibili 259
AF - Africa 75
OC - Oceania 3
Totale 9.679
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.832
SG - Singapore 1.281
IT - Italia 470
BR - Brasile 450
CN - Cina 387
IE - Irlanda 378
RU - Federazione Russa 375
HK - Hong Kong 314
VN - Vietnam 230
FR - Francia 162
DE - Germania 150
UA - Ucraina 127
SE - Svezia 109
FI - Finlandia 103
GB - Regno Unito 95
CA - Canada 75
BD - Bangladesh 66
IN - India 54
KR - Corea 54
TR - Turchia 41
IQ - Iraq 37
MX - Messico 37
AR - Argentina 29
AT - Austria 26
PK - Pakistan 23
EC - Ecuador 22
PL - Polonia 22
CO - Colombia 20
UZ - Uzbekistan 20
CR - Costa Rica 16
TT - Trinidad e Tobago 15
VE - Venezuela 15
ZA - Sudafrica 15
JP - Giappone 14
CW - ???statistics.table.value.countryCode.CW??? 13
ID - Indonesia 13
MA - Marocco 13
BE - Belgio 12
ES - Italia 12
GT - Guatemala 12
IL - Israele 12
PH - Filippine 10
SA - Arabia Saudita 10
TN - Tunisia 10
CL - Cile 9
EG - Egitto 9
JO - Giordania 9
NL - Olanda 9
CH - Svizzera 8
JM - Giamaica 8
LT - Lituania 8
MY - Malesia 8
PE - Perù 8
PR - Porto Rico 8
PY - Paraguay 8
SV - El Salvador 8
KE - Kenya 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
NI - Nicaragua 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
DZ - Algeria 5
HN - Honduras 5
LB - Libano 5
NP - Nepal 5
OM - Oman 5
UY - Uruguay 5
AO - Angola 4
GP - Guadalupe 4
GR - Grecia 4
KZ - Kazakistan 4
BO - Bolivia 3
DK - Danimarca 3
EE - Estonia 3
ET - Etiopia 3
GY - Guiana 3
KW - Kuwait 3
PS - Palestinian Territory 3
RO - Romania 3
TH - Thailandia 3
AU - Australia 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
KG - Kirghizistan 2
PT - Portogallo 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BZ - Belize 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GF - Guiana Francese 1
Totale 9.415
Salva come PNG Salva come JPEG
Città #
Singapore 900
San Jose 438
Dublin 377
Ashburn 363
Chandler 325
Hong Kong 312
San Mateo 176
Santa Clara 161
Council Bluffs 144
Moscow 138
Perugia 128
Boardman 125
Altamura 121
Lauterbourg 98
Princeton 93
Ann Arbor 91
Medford 91
Lawrence 89
Beijing 87
Dong Ket 86
Los Angeles 67
Jacksonville 62
Munich 57
Ho Chi Minh City 56
Seoul 54
New York 52
Wilmington 48
Andover 46
São Paulo 46
The Dalles 43
Redmond 36
North Bergen 35
Hanoi 34
Des Moines 31
Dallas 30
Phoenix 26
Piscataway 24
Orem 23
Rome 23
Turku 23
Montreal 22
Nuremberg 22
Helsinki 21
Rio de Janeiro 20
Chennai 19
Frankfurt am Main 19
Redwood City 19
Saint Petersburg 19
Brooklyn 16
Baghdad 15
Izmir 15
London 15
Milan 15
Norwalk 14
San Paolo di Civitate 14
Woodbridge 14
Amelia 13
Charlotte 13
Houston 13
San José 13
Tokyo 13
Willemstad 13
Brussels 12
Chicago 12
Tashkent 12
Atlanta 11
Belo Horizonte 11
Boston 11
Brasília 11
Columbus 11
Denver 11
Manchester 11
Shanghai 11
Toronto 11
Warsaw 11
Buffalo 10
Guatemala City 10
Stockholm 10
Lahore 9
Amman 8
Bologna 8
Mexico City 8
New Orleans 8
Vienna 8
Campinas 7
Chaguanas 7
Curitiba 7
Falkenstein 7
Haiphong 7
Istanbul 7
Johannesburg 7
Nairobi 7
Naples 7
Poplar 7
Quito 7
San Francisco 7
Seattle 7
Caracas 6
Da Nang 6
Dhaka 6
Totale 5.850
Salva come PNG Salva come JPEG
Nome #
The sentinel node biopsy in patients with thick melanoma:outcome analysis from a single-institution database 172
Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis. 158
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 152
Aspirin for preventing the recurrence of venous thromboembolism. 148
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 134
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 133
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 131
Antecolic or Retrocolic Alimentary Limb in Laparoscopic Roux-en-Y Gastric Bypass? A Meta-Analysis 129
Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis 118
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 118
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. 117
Thrombophilia and cerebral vein thrombosis 116
A new strategy for anticoagulation: The factor XI inhibitors 115
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study 114
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 112
[ANMCO position paper: Use of new oral anticoagulants for the treatment and prevention of pulmonary thromboembolism] 111
Incidence of venous thromboembolism in patients undergoing laparoscopic surgery for colorectal cancer 110
Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation 110
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 109
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 109
Carotid plaque detection improves the predictve value of CHA 2 DS 2 -VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 107
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 106
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation 103
[2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism: what's new?] 103
Vitamin K and non-vitamin K antagonists oral anticoagulants for non-valvular atrial fibrillation in real-life 101
Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation 100
PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort 99
Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism 99
Prognostic value of respiratory index in haemodynamically stable patients with acute pulmonary embolism: The Respiratory Index model study 98
Efficacy and safety of two heparin regimens for prevention of venous thromboembolism in hospitalized patients with COVID-19: a meta-analysis 97
A Randomized Study on 1-Week Versus 4-Week Prophylaxis for Venous Thromboembolism After Laparoscopic Surgery for Colorectal Cancer Reply 96
Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer 96
Rivaroxaban versus placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer 96
Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence 95
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. 95
Multidetector CT scan for acute pulmonary embolism: Embolic burden and clinical outcome 95
Oxygen saturation or respiratory rate to improve risk stratification in hemodynamically stable patients with acute pulmonary embolism 95
Beyond the guidelines: Novelties, changes and unsolved issues from the 2019 ESC guidelines on pulmonary embolism 95
Accuracy of Physicians in Differentiating Type 1 and Type 2 Myocardial Infarction Based on Clinical Information 95
Direct oral anticoagulants in patients with VTE and cancer: A systematic review and meta-analysis 94
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 93
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 93
Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study 93
Risk Factors for Intracerebral Hemorrhage in Patients with Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 93
Combined oral anticoagulants and antiplatelets: benefits and risks. 91
Intra-abdominal drainage after pancreatic resection: Is it really necessary? A meta-analysis of short-term outcomes 90
Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation 88
Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis 88
A randomized study on 1 vs. 4 weeks prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer 87
Predictors of new onset atrial fibrillation after myocardial infarction 86
Patients with acute pulmonary embolism at intermediate risk for death: Can we further stratify? 85
Thrombotic risk after a major bleeding during anticoagulation: A clinical case 84
Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: A prospective cohort study 84
Fixed-dose rivaroxaban is not associated with increased recurrent venous thromboembolism or major bleeding in patients with a high or low body weight 82
Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants 82
Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism 81
Cerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study 81
[Pulmonary hypertension associated with left heart diseases: pathophysiology, diagnosis, treatment] 81
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 81
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. 80
Efficacy of rivaroxaban for thromboprophylaxis after knee arthroscopy (ERIKA): A phase ii, multicentre, double-blind, placebo-controlled randomised study 80
Reply 80
Clinical prediction models in hospitalized patients with COVID-19: A multicenter cohort study 79
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 74
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study 74
Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models 73
Prognostic value of troponins in acutepulmonary embolism: a meta-analysis. 73
Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort 73
Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis 73
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study 72
Sex-specific differences in the presentation, clinical course, and quality of life of patients with acute venous thromboembolism according to baseline risk factors. Insights from the PREFER in VTE 72
Risk factors for cerebral ischemic events in patients with atrial fibrillation on warfarin for stroke prevention. 71
Prognostic value of the CHA2DS2Vasc score in patients experiencing a myocardial infarction 71
Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study 71
Diagnosis and prognosis of acute pulmonary embolism: focus on serum troponins. 70
To drain or not to drain extraperitoneal colorectal anastomosis? A systematic review and meta-analysis. 70
Diagnosis of infection by SARS-COV-2: Is one molecular test enough? 70
One week vs. four week heparin prophylaxis after laparoscopic surgery for colorectal cancer. The pro-laps pilot feasibility study 69
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis 69
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies 68
[A new anticoagulant strategy: the factor XI inhibitors] 68
To drain or not to drain elective uncomplicated laparoscopic cholecystectomy? A systematic review and meta-analysis 66
MDCT-detected embolic burden and clinical outcome in patients with acute pulmonary embolism 66
Multidetectorcomputed tomography for acute pulmonary embolism: diagnosis and riskstratification in a single test. 65
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience 64
Old and new oral anticoagulants forvenous thromboembolism and atrial fibrillation: A review of the literature. 64
Risk factors and one-year mortality in patients with direct oral anticoagulant-associated gastrointestinal bleeding 64
Novel oral anticoagulants for patients with venous thromboembolism and active cancer: a systematic review and meta-analysis 63
Right ventricle dysfunction in patients with pulmonary embolism. 62
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. 62
Efficacy and safety of direct oral anticoagulants after pulmonary embolism: A meta-analysis 62
Prognostic role of embolic burden assessed at computed tomography angiography in patients with acute pulmonary embolism: systematic review and meta-analysis 61
Incidence of arterial cardiovascular events after venous thromboembolism: a systematic review and a meta-analysis. 60
Relationship between carotid intima-media thickness and non valvular atrial fibrillation type 60
Venous thromboembolism and COVID-19: Mind the gap between clinical epidemiology and patient management 60
Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis 59
Computed tomography to assess risk of death in acute pulmonary embolism: a meta-analysis. 58
Novel oral anticoagulants in patients with venous thromboembolism and active cancer: a systematic review and meta-analysis 58
Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service 58
[Anticoagulation therapy during pulmonary embolism follow-up in clinical practice] 57
Totale 8.893
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.646
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022532 0 0 0 0 32 4 8 206 24 59 91 108
2022/20231.272 94 293 18 71 76 121 0 45 493 5 33 23
2023/2024496 26 54 29 9 6 1 107 3 41 35 104 81
2024/20251.594 18 130 45 89 238 59 76 106 340 103 260 130
2025/20263.269 231 191 181 467 423 253 617 193 329 258 89 37
2026/20271.369 81 166 268 738 116 0 0 0 0 0 0 0
Totale 9.679